fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

An open letter to the Alzheimer’s disease community from Biogen Head of Research and Development, Alfred Sandrock, M.D., Ph.D

Written by | 27 Jul 2021

Statement from Head of Research and Development, Alfred Sandrock, M.D., Ph.D.:Biogen Inc. – On June 7, 2021, Aduhelm became the first approved treatment to address a defining pathology… read more.

Exercise likely to be best treatment for depression in coronary heart disease

Written by | 24 Jul 2021

A study by RCSI indicates that exercise is probably the most effective short-term treatment for depression in people with coronary heart disease, when compared to antidepressants and psychotherapy… read more.

Protecting the intellectual abilities of people at risk for psychosis

Written by | 23 Jul 2021

Université de Genève One person in 2000 suffers from a microdeletion of chromosome 22 that can lead to the development of psychotic disorders, such as schizophrenia, in adolescence…. read more.

Laughing gas relieves symptoms in people with treatment-resistant depression

Written by | 21 Jul 2021

Washington University School of Medicine A single, one-hour treatment that involves breathing in a mixture of oxygen and nitrous oxide — otherwise known as laughing gas — significantly… read more.

Antidepressant prescribing during covid-19

Written by | 2 Jul 2021

Interview and article by Christine Clark. Some four million extra prescriptions for antidepressants were issued in 2020 compared to 2019 but the cost to the NHS increased by… read more.

Waking just one hour earlier cuts depression risk by double digits, study finds

Written by | 23 Jun 2021

Waking up just one hour earlier could reduce a person’s risk of major depression by 23%, suggests a sweeping new genetic study published May 26 in the journal JAMA… read more.

Simple diagnostic tool predicts individual risk of Alzheimer’s

Written by | 13 Jun 2021

Researchers at Lund University in Sweden have developed an algorithm that combines data from a simple blood test and brief memory tests, to predict with great accuracy who… read more.

Mothers’ depression impacts mother-infant relationships

Written by | 9 Jun 2021

Women with depression during pregnancy, or with a history of depression, had a reduced quality of mother-infant interaction. In a study funded by National Institute for Health Research… read more.

Fluvoxamine for early treatment of covid-19

Written by | 8 Jun 2021

Article by Christine Clark. Evidence from trials and real world experience shows that selective serotonin reuptake inhibitors (SSRIs) are effective in treating acute covid and preventing long-haul covid.

Rejuvenating’ the Alzheimer’s brain

Written by | 8 Jun 2021

Alzheimer’s disease is the main cause of dementia and current therapeutic strategies cannot prevent, slow down or cure the pathology. The disease is characterized by memory loss, caused… read more.

FDA approves Lybalvi for schizophrenia and bipolar I disorder – Alkermes

Written by | 2 Jun 2021

Alkermes announced that the FDA has approved Lybalvi (olanzapine and samidorphan) for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder,… read more.

Changes in how cholesterol breaks down in the body may accelerate progression of dementia

Written by | 2 Jun 2021

Study suggests that some cholesterol medications may impact signaling pathways in the brain, particularly in men The blood-brain barrier is impermeable to cholesterol, yet high blood cholesterol is… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.